HKDC1 in Cancer: Mechanisms, Clinical Applications, and Future
Journal of Cancer · 22.08.2025 · 16 (13) · 3851-3858
DOI: 10.7150/jca.116277 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cancer, erschienen am 22.08.2025. Verfasst von Xia Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of the Central Laboratory, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, C…. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of the Central Laboratory, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha 410013, Hunan, China.
- Lung Cancer and Gastrointestinal Unit, Department of Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University /Hunan Cancer Hospital, Changsha 410031, China.
Zitieren
APA
Luo, X., Peng, M., Wang, Z., Wu, N., & Wang, Y. (2025). HKDC1 in Cancer: Mechanisms, Clinical Applications, and Future. Journal of Cancer, 16(13), 3851-3858. https://doi.org/10.7150/jca.116277
Vancouver
Luo X, Peng M, Wang Z, Wu N, Wang Y. HKDC1 in Cancer: Mechanisms, Clinical Applications, and Future. Journal of Cancer. 2025;16(13):3851-3858. doi:10.7150/jca.116277
BibTeX
@article{Luo2025,
author = {Luo, Xia and Peng, Mingjing and Wang, Zhan and Wu, Nayiyuan and Wang, Ying},
title = {HKDC1 in Cancer: Mechanisms, Clinical Applications, and Future},
journal = {Journal of Cancer},
year = {2025},
volume = {16},
number = {13},
pages = {3851--3858},
doi = {10.7150/jca.116277}
}
EUVIMED